8 results
Diabetes Medications Summary Table
Insulin
Lifestyle modifications
Metformin
Sulfonylureas
GLP-1 receptor agonists - ↓ major adverse CV events
TZDs
DPP-4 inhibitors
SGLT2 inhibitors -
Diabetes Medications ... Summary Table ... Improved outcomes in CKD ... #medications #table ... endocrinology #dm2
Phosphate binders - quick reference chart of maximum daily dose. Most patients with CKD will require
maximum daily dose ... patients with CKD ... since they are not able ... Purposes Only* #CKD ... PhosphateBinders #Hyperphosphatemia
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
Patients With CKD ... increase in the dose ... an increase in dose ... ml/min per 1.73 m2 ... #Diabetes #CKD #
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... Calculate total daily dose ... Adjust insulin dose ... #Mellitus #DM2 ... pharmacology #comparison #table
Estimating the Total Daily Dose (TDD) of Insulin: Weight-Based Dosing
TDD in units of insulin = N
the Total Daily Dose ... (stage IV or V CKD ... including most 2 diabetics ... endocrinology #diabetes ... #DM2
Causes of Chronic Kidney Disease - Differential Diagnosis Algorithm
Decreased kidney function (eGFR < 60 ml/min/1.73 m2)
60 ml/min/1.73 m2 ... Proteinuria) • Diabetes ... Hypercalcemia • Hyperphosphatemia ... #CKD #Chronic
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Does the patient ... metabolic equivalent able ... Insulin dependent DM ... Stable patients ... Diabetes regimen
Hyperkalemia - Diagnosis and Management - GrepMed Handbook

S/Sx: Most pts asymptomatic. Weakness, cramping, nausea, paresthesias, palpitations,
transfusions), ↓insulin (DM ... VBG (acidosis), CK ... Elimination (see Table ... Transient, repeat dose